Clinical Trial Update: Effect of Pentoxifylline on Cognitive Impairment After Ischemic Stroke [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on pentoxifylline for cognitive impairment after ischemic stroke, currently in Phase 1 and Phase 2 with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment After Ischemic Stroke

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: The First Hospital of Hebei Medical University | Conditions: Cognitive Impairment | Phase 1, Phase 2 | Status: UNKNOWN